Catalyst Watch: key earnings, IPOs, dividends, macro data (GDP, core PCE) and events like Davos that could move stocks next ...

Johnson & Johnson (NYSE: JNJ) is among the most profitable US stocks to buy. On January 9, Lee Hambright at Bernstein raised ...

As bank earnings roll in, follow along for live updates on markets and the top finance, economics and business stories. Plus the latest on the Dow, S&P 500 and Nasdaq.

Johnson & Johnson reports Phase 3 results showing Tecvayli reduced disease progression and deaths in multiple myeloma ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

Live updates on markets and the top finance, economics and business stories. Plus the latest on the Dow, S&P 500 and Nasdaq.

Johnson & Johnson struck a deal with the Trump administration to lower drug prices for U.S. consumers in exchange for ...

Investing in dividend-paying stocks is one of numerous approaches that can help you maximize your portfolio growth, and ...

Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the JNJ ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...

Johnson & Johnson has just undergone its most significant transformation in decades. In 2023, the consumer health segment was spun off as Kenvue. Now, the orthopedic division is set to be separated as ...

Federal regulators are investigating Tesla's emergency door release systems on its Model 3 and Model Y vehicles. A separate investigation into the Model Y's emergency door handles began in September ...